{
  "id": "cluster_33_doc2",
  "content": "Provider memo dated 02/14/2024: Patient #RC-88345 (age 12) with confirmed xanthoprotease deficiency began biweekly Veltamase infusions at Albany Children's Specialty Clinic. Treatment plan includes quarterly metabolic panels and biannual liver function tests. Parents report improved school attendance since starting therapy. Prior authorization submitted under Policy #MET-445 revisions enacted 10/2023.",
  "metadata": {
    "format": "provider_report"
  }
}